Copyright
©2011 Baishideng Publishing Group Co.
World J Clin Oncol. Jul 10, 2011; 2(7): 281-288
Published online Jul 10, 2011. doi: 10.5306/wjco.v2.i7.281
Published online Jul 10, 2011. doi: 10.5306/wjco.v2.i7.281
Reference | Year | Prior treatment | Maintenance schedule | No. of patients | Median F-up | PFS | OS |
Haisworth et al[16] | 2005 | R x 4 (weekly) | R x 4 (weekly) every 6 mo x 4 vs R x 4 weekly at relapse (retreatment) | 62 | 41 mo | 31.3 vs 7.4 mo (P = 0.007) | 72% vs 68% at 3 years (P = NS) |
Ghielmini et al[14] Martinelli et al[19] | 2004 | R x 4 (weekly) | R every 2 mo x 4 vs observation | 185 | 9.5 years | 24 vs 13 mo (P < 0.001) | 68% vs 54% (P = 0.081) |
2010 |
- Citation: Arcaini L, Merli M. Rituximab maintenance in follicular lymphoma patients . World J Clin Oncol 2011; 2(7): 281-288
- URL: https://www.wjgnet.com/2218-4333/full/v2/i7/281.htm
- DOI: https://dx.doi.org/10.5306/wjco.v2.i7.281